Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
Adrenergic Agents
/ pharmacology
Animals
Corpus Striatum
/ metabolism
Dopamine
/ metabolism
GABAergic Neurons
/ metabolism
Inhibitory Postsynaptic Potentials
/ physiology
Interneurons
/ metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Neuropeptide Y
/ metabolism
Oxidopamine
/ pharmacology
Patch-Clamp Techniques
Synaptic Transmission
/ physiology
GABAergic IPSCs
NPY interneurons
dopamine depletion
Journal
Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
pubmed:
12
3
2020
medline:
22
6
2021
entrez:
12
3
2020
Statut:
ppublish
Résumé
As the main input nucleus of the basal ganglia, the striatum plays a central role in planning, control, and execution of movement and motor skill learning. More than 90% of striatal neurons, so-called medium spiny neurons (MSN), are GABAergic projection neurons, innervating primarily the substantia nigra pars reticulata or the globus pallidus internus. The remaining neurons are GABAergic and cholinergic interneurons, synchronizing and controlling striatal output by reciprocal connections with MSN. Besides prominent local cholinergic influence, striatal function is globally regulated by dopamine (DA) from the nigrostriatal pathway. Little is known about whether DA depletion, as occurs in Parkinson's disease, affects the activity of striatal interneurons. Here we focused on neuropeptide Y (NPY)-expressing interneurons, which are among the major subgroups of GABAergic interneurons in the striatum. We investigated the effects of striatal DA depletion on GABAergic transmission in NPY interneurons by electrophysiologically recording GABAergic spontaneous (s) and miniature (m) inhibitory postsynaptic currents (IPSCs) in identified NPY interneurons in slices from 6-hydroxydopamine (6-OHDA)- and vehicle-injected transgenic NPY-humanized
Identifiants
pubmed: 32159408
doi: 10.1152/jn.00059.2020
doi:
Substances chimiques
Adrenergic Agents
0
Neuropeptide Y
0
Oxidopamine
8HW4YBZ748
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM